BOULDER, Colo., Oct. 29 /PRNewswire-FirstCall/ -- Tapestry Pharmaceuticals, Inc. (NASDAQ:TPPH) announced today that management will provide a company update at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on November 5, 2007 at 9:50 a.m. Eastern Time. The conference is being held at The New York Palace Hotel in New York City.
A live audio webcast of the presentation will be available on the "Investors" section of the company's website at http://www.tapestrypharma.com/. The webcast will be archived and available on the Tapestry website after the event for a period of 30 days.
About Tapestry Pharmaceuticals, Inc.
Tapestry Pharmaceuticals, Inc. is a company focused on the development of proprietary therapies for the treatment of cancer. For more information about Tapestry and its technologies, visit Tapestry's website at http://www.tapestrypharma.com/.
Contact: Tapestry Pharmaceuticals, Inc. Gordon Link
Senior Vice President, Chief Financial Officer
303-516-8500
Investor: Laura Perry
Stern Investor Relations, Inc. 212-362-1200
Media: Dana Conti
Schwartz Communications, Inc. 781-684-0770
DATASOURCE: Tapestry Pharmaceuticals, Inc.
CONTACT: Gordon Link, Senior Vice President, Chief Financial Officer of Tapestry Pharmaceuticals, Inc., +1-303-516-8500, , or Investors, Laura Perry of Stern Investor Relations, Inc., +1-212-362-1200, , or Media, Dana Conti of Schwartz Communications, Inc., +1-781-684-0770, , both for Tapestry Pharmaceuticals, Inc. Web site: http://www.tapestrypharma.com/
|